The global multiomic industry is witnessing a transformative surge, expected to grow from USD 3.9 billion in 2024 to an impressive USD 15.3 billion by 2034, at a remarkable compound annual growth rate (CAGR) of 14.8%. The increasing prevalence of chronic diseases and complex health conditions has created a pressing need for comprehensive, integrated approaches to …